Novel Haemostatic Techniques In Military Medicine

Mahoney, PF; Rußell, Robert; Russell, MQ; Hodgetts, Tim

doi:10.1136/jramc-151-03-01

Cited by 13 publications

(5 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Two haemostatic products have been used successfully, QuikClot & HemCon (Arnaud et al, 2008, Marcus, 2008Mahoney et al, 2005). Haemcon, derived from chitosan in seashells, used in the form of impregnated dressings was adopted by DMS and is recommended in control of ''junctional areas and high pressure bleeding'' (Hodgetts and Mahoney, 2007, p. 13).…”

Section: Combat Application Tourniquet (Cat) and Novel Haemostaticsmentioning

confidence: 99%

An upshot of war – Damage control resuscitation

Byers

2010

International Emergency Nursing

View full text Add to dashboard Cite

Section: Combat Application Tourniquet (Cat) and Novel Haemostaticsmentioning

confidence: 99%

An upshot of war – Damage control resuscitation

Byers

2010

International Emergency Nursing

View full text Add to dashboard Cite

“…It must also be ‘better’, either because it performs the same function more efficiently (and specifically is cheaper, with greater value for money), or it improves outcome (at the same or an acceptable incremental cost), or it is an unforeseen step change in capability. The latter is exemplified by the introduction of topical haemostasis at the point of injury in UK military practice from 2004 4 5…”

Section: The Meaning Of ‘Innovation’mentioning

confidence: 99%

A roadmap for innovation

Hodgetts

2014

J R Army Med Corps

View full text Add to dashboard Cite

Medicine has historically advanced during conflict, but military medical services have consistently regressed during peace. As over a decade of campaigning in Iraq and Afghanistan draws to a close, securing the legacy of hard won clinical lessons and retaining flexibility to adapt to new patterns of illness and injury during contingency is critical. Central to sustaining exceptional outcomes for future operations and to maintaining the current position of the Defence Medical Services as providers of clinical excellence is retaining the capability to innovate. This capability must extend across the spectrum of clinical innovation-concepts, guidelines, equipment (invention and adoption), curricula (design, assessment and refinement), research and Defence diplomacy. To achieve this requires a strategy, a 'roadmap', with a clear vision, end state and centres of gravity (core strengths that must be protected). The direction for innovation will be guided by emergent analysis of the future character of military medicine. Success will be determined by ensuring the conditions are met to protect and enhance the existing 'winning culture'.

show abstract

“…Conflict has historically driven advances in military medicine. Sustained casualty rates since 2003 for UK military personnel on Operation Telic (Iraq) and Operation Herrick (Afghanistan) have been the stimulus to develop new paradigms of care [1] and structured practice guidelines [2], to accelerate the introduction of technological advances [3,4], to dynamically enhance supporting curricula [5,6] and to take a total quality system audit approach to combat casualty care [7].…”

Section: Introductionmentioning

confidence: 99%

Damage Control Resuscitation

Jansen¹

2020

View full text Add to dashboard Cite

Novel Haemostatic Techniques In Military Medicine

Cited by 13 publications

References 6 publications

An upshot of war – Damage control resuscitation

An upshot of war – Damage control resuscitation

A roadmap for innovation

Damage Control Resuscitation

Contact Info

Product

Resources

About